Pioneering AI in life sciences company grows team in the Basel Area
Country of origin
France & US
Owkin develops solutions for the life sciences industry based on artificial intelligence and machine learning to help them develop the most effective treatments fast and at scale.
AI and machine learning for better collaboration.
Owkin was founded in 2016 and operates out of locations in France, the USA, the UK—and now Switzerland.
Owkin develops AI and machine learning solutions for the life sciences industry to drive forward developments, particularly in precision medicine.
With its platform, Owkin connects life sciences companies with academic researchers and hospitals to share medical insights for drug discovery and development. This collaboration helps unlock new insights from siloed, multimodal datasets.
The future of Owkin in the Basel Area.
With its new branch office in Basel, Owkin wants to secure its growth across Europe and further beyond.
The Basel Area is the perfect location as one of Europe’s largest life sciences clusters. Owkin can find potential partners and great talent to support its future growth here.
”Owkin‘s mission is to develop cutting-edge AI technologies that help doctors to find the right treatment for every patient. But to achieve that, we must work closely with pharmaceutical partners, hospitals, and research institutions across the world. Establishing a presence in Basel—Owkin‘s fourth, after France, the United States, and the United Kingdom—will enable us to connect with leading partners while also helping to attract more of the best talent possible.Sezai TaskinSVP of Strategic Business Development, Owkin